85JPY
6.65 BJPY
103.26 BJPY
16.49 M
About MOCHIDA PHARMACEUTICAL CO
Sector
Headquarters
Tokyo
Employees (FY)
1.53 K
Website
Founded
1913
ISIN
JP3922800002
FIGI
BBG000BJYC65
Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. It operates through following business divisions: Pharmaceuticals and Healthcare Products. The Pharmaceuticals division conducts research and development for medical needs. The Healthcare Products division manufactures and sells cosmetic and medicated products. It also manufactures and sells prescription drugs for cardiovascular, obstetrics and gynecology, dermatology, emergency and psychiatric ailments. The company was founded by Ryokichi Mochida in February 1913 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4534 is 3155 JPY — it has decreased by 0.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange MOCHIDA PHARMACEUTICAL CO stocks are traded under the ticker 4534.
MOCHIDA PHARMACEUTICAL CO is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
4534 stock is 0.64% volatile and has beta coefficient of 0.43. Check out the list of the most volatile stocks — is MOCHIDA PHARMACEUTICAL CO there?
MOCHIDA PHARMACEUTICAL CO revenue for the last quarter amounts to 24.73 B JPY despite the estimated figure of 25.05 B JPY. In the next quarter revenue is expected to reach 27.82 B JPY.
Yes, you can track MOCHIDA PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
4534 stock has risen by 0.96% compared to the previous week, the month change is a 3.37% fall, over the last year MOCHIDA PHARMACEUTICAL CO has showed a 8.82% decrease.
4534 net income for the last quarter is 1.61 B JPY, while the quarter before that showed 1.15 B JPY of net income which accounts for 39.65% change. Track more MOCHIDA PHARMACEUTICAL CO financial stats to get the full picture.
Today MOCHIDA PHARMACEUTICAL CO has the market capitalization of 109.18 B, it has increased by 0.16% over the last week.
MOCHIDA PHARMACEUTICAL CO dividend yield was 2.40% in 2022, and payout ratio reached 44.71%. The year before the numbers were 2.41% and 32.45% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4534 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOCHIDA PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 1.53 K employees. See our rating of the largest employees — is MOCHIDA PHARMACEUTICAL CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOCHIDA PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOCHIDA PHARMACEUTICAL CO stock shows the strong sell signal. See more of MOCHIDA PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MOCHIDA PHARMACEUTICAL CO future price: according to them, 4534 price has a max estimate of 3200.00 JPY and a min estimate of 3200.00 JPY. Read a more detailed MOCHIDA PHARMACEUTICAL CO forecast: see what analysts think of MOCHIDA PHARMACEUTICAL CO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOCHIDA PHARMACEUTICAL CO EBITDA is 6.70 B JPY, and current EBITDA margin is 10.83%. See more stats in MOCHIDA PHARMACEUTICAL CO financial statements.